| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a693c935313689398a7657962c9a1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_410c7dbe27efe470ff1a027f5217d385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280d87031f0c5786de1808713a1b76b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0705539c69b72e9620aa3dc5826a927d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d452363d025ff2abdd58dfeac7b7f2bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1bf73742c2a23742f3d1343452bc728 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-12043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2014-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba60eb8281771be2119083c1b02fa647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86087f693f832c6a2caf40858b208a1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71bb9279ab0ae763d14ab98e24d035ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_561565fe53ee459e177f2fa6c5adb43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3c83848cbf8acf63d042084987e87c |
| publicationDate |
2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015368660-A1 |
| titleOfInvention |
Geminiviral vector for expression of rituximab |
| abstract |
A single vector or multiple separate vectors that contain two or more non-competing replicons for transient expression of the heavy and light chains of Rituximab in Nicotiana benthamiana leaves is described. The correct assembly of these subunit proteins into functional oligomeric structures to optimize the expression is also described. This system advances plant transient expression technology by eliminating the need for non-competing viruses, and thus, enhances the realistic commercial application of the multi-replicon single vector system for producing Rituximab in plant cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019169409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9506079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447789-B2 |
| priorityDate |
2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |